Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyKaren Sliwa, John J.V. McMurray, Denise Hilfiker‐Kleiner et al.|European Journal of Heart Failure|2010Cited by 1.1k
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Gad Cotter, Beth A. Davison et al.|The Lancet|2022Cited by 1k
Acute heart failureMattia Arrigo, Alexandre Mebazaa, Mariell Jessup et al.|Nature Reviews Disease Primers|2020Cited by 566
Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyJohann Bauersachs, Karen Sliwa, Tobias König et al.|European Journal of Heart Failure|2019Cited by 435
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathyAiden Haghikia, Denise Hilfiker‐Kleiner, Edith Podewski et al.|Basic Research in Cardiology|2013Cited by 351